The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
Open accessAbstract
NK cells are involved in the immune response against viral and microbial infections and tumors. In contrast to B and T cells, NK cells employ various modes of immune recognition. An important mode of immune recognition employed by NK cells is "induced self recognition" exemplified by the NKG2D receptor–ligand system. The NKG2D immunoreceptor, expressed by NK cells, and by activated CD8+ T cells and macrophages, recognizes one of several cell surface ligands that are distantly related to MHC class I molecules (i.e. H60 and Rae1 proteins in mice, and MHC class I chain‐related proteins and UL‐16‐binding proteins in humans). These ligands are not expressed abundantly by most normal cells but are up‐regulated on cells exposed to various forms of cellular insults.Here we report the cloning of another ligand for NKG2D; transcripts of this ligand are found in a wide variety of tissues and in various tumor cells. Cross‐linking of NKG2D with the novel ligand potently activated NK cells and macrophages. Tumor cells ectopically expressing the molecule were efficiently rejected by naive mice, and induced strong protective immunity to the parental, ligand‐negative tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J., Lanier, L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 3,272
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,267
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W. A., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,394
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–169 of 169
DAP10 Deficiency Breaks the Immune Tolerance against Transplantable Syngeneic Melanoma
Hyka‐Nouspikel, N., Lucian, L. A., Murphy, E. A., McClanahan, T., & Phillips, J. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3763 · Cited by 15
Kotturi, H. S. R., Li, J., Branham-O’Connor, M., Stickel, S. L., Yu, X., Wagner, T. E., & Wei, Y. (2008) · Gene Therapy · doi:10.1038/gt.2008.77 · Cited by 13
NK Cell‐mediated Destruction of Influenza A Virus‐infected Peripheral but not Central Neurones
Backström, E., Ljunggren, H., & Kristensson, K. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01912.x · Cited by 15
Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura
Cooper, E. L. (2004) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neh011 · Cited by 13
Buhtoiarov, I., Rakhmilevich, A., Lanier, L., Ranheim, E., & Sondel, P. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0800443 · Cited by 13
Immunological Aspects of Axon Injury in Multiple Sclerosis
Howe, C. L. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6_5 · Cited by 11
The dynamics of natural killer cell tolerance
Johansson, M. H., & Höglund, P. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.013 · Cited by 12
Folli, C., Chiappori, A., Pellegrini, M., Garelli, V., Riccio, A., Ferrari, L. D., Braido, F., & Canonica, G. W. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.06.009 · Cited by 11
Natural Killer cells in Innate Defense against Infective Pathogens
Yongchao, D. W. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s13-006 · Cited by 11
Biassoni, R., Ugolotti, E., & Maria, A. D. (2010) · Self/Nonself · doi:10.4161/self.1.2.11717 · Cited by 10
Wu, P. (2005) · Frontiers in bioscience · doi:10.2741/1770 · Cited by 10
Pinto, A. K., Jamieson, A. M., Raulet, D. H., & Hill, A. B. (2007) · Journal of Virology · doi:10.1128/jvi.01328-07 · Cited by 10
Self-citationFlanagan, M. L., Khawli, L. A., Hu, P., & Epstein, A. L. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000199194.90222.1a · Cited by 9
Thompson, H. L., van Rooijen, N., McLelland, B. T., & Manilay, J. O. (2016) · Journal of Immunology Research · doi:10.1155/2016/2414906 · Cited by 9
Development and Function of Natural Killer Cells and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809819-6.00009-5 · Cited by 8
Holubeková, V., Loderer, D., Grendár, M., Mikolajčík, P., Kolková, Z., Turyova, E., Kúdelová, E., Kalman, M., Marcinek, J., Miklušica, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1206482 · Cited by 7
Campos‐Silva, C., López-Borrego, S., Felgueres, M. J., Esteso, G., & Valés‐Gómez, M. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022045263 · Cited by 7
In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors
Kotturi, H. S. R., Li, J., Branham-O’Connor, M., Yu, X., Wagner, T. E., & Wei, Y. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.69 · Cited by 7
Trembath, A. P., Sharma, N., Raju, S., Polić, B., & Markiewicz, M. A. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700011 · Cited by 6
MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation
Tietje, A. H., Li, J., Yu, X., & Wei, Y. (2014) · Gene Therapy · doi:10.1038/gt.2014.15 · Cited by 6
Li, X., Wong, C., Mysel, R., Slobodov, G., Metwalli, A. R., Kruska, J. D., Manatt, C. S., Culkin, D. J., Kropp, B. P., & Lin, H. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-30 · Cited by 6
Novel mobilization strategies to enhance autologous immune effector cells in multiple myeloma
Meehan, K. R. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e351 · Cited by 4
Jänner, N., Hahnke, K., Mollenkopf, H., Steinhoff, U., Kaufmann, S. H. E., & Mittrücker, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02817.x · Cited by 4
Roles of dendritic epidermal T cells in steady and different pathological states
Hao, J., Zhang, J., & Liu, Y. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae056 · Cited by 3
Detecting the Unusual: Natural Killer Cells
Volz, A., & Radeloff, B. (2006) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(06)81012-3 · Cited by 3
O’Callaghan, C. A. (2009) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001666.01 · Cited by 3
NKG2D-Based Cancer Immunotherapy
Wu, J. D., & Wang, X. (2011) · InTech eBooks · doi:10.5772/23523 · Cited by 2
Dammeyer, P., Mwakigonja, A. R., Réthi, B., Chiodi, F., & Wolpert, E. Z. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02270.x · Cited by 2
Gervais, A., Toutirais, O., Bouet-Toussaint, F., Pintière, C. T. D. L., Genetet, N., & Quémener, V. (2007) · PubMed · Cited by 2
Diefenbach, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00004-2 · Cited by 2
Self-citationMembrane-Based Assembly and Interactions in Immune Receptors
Call, M. E., & Call, M. J. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00993 · Cited by 1
Gupta, R. K., & Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_31 · Cited by 1
Ulbar, F., Nicolini, B., Chirumbolo, G., Tolomelli, G., Steinle, A., Rondelli, D., & Arpinati, M. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.10.001 · Cited by 1
Cancer Gene Therapy via NKG2D and FAS Pathways
Wei, Y., Li, J., & Kotturi, H. S. R. (2011) · InTech eBooks · doi:10.5772/17386 · Cited by 1
Cellular Cytotoxicity and Multiple Sclerosis
Willson, A. M. L., & Jordan, M. A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105681 · Cited by 1
Khan, S. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22198 · Cited by 1
Hu, H., Chu, Y., & Urba, W. J. (2005) · Cancer treatment and research · doi:10.1007/0-387-27545-2_9 · Cited by 1
Chauvin, C. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
NK CELL RECOGNITION OF HERPESVIRUSES – MECHANISMS OF VIRAL IMMUNE ESCAPE
Rölle, A. (2008) · Figshare · doi:10.13140/2.1.1557.5365
Role of IL-21 in regulation of leukocyte functions
Strengell, M. (2005) · Työväentutkimus Vuosikirja
Phospholipase C Isoform Functions in Immune Cells
Vines, C. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0464-8_13
Орлова, С. Н. (2007) · DSpace repository (University of Tartu)
Whang, M. I., Guerra, N., & Raulet, D. H. (2009)
Self-citationTherapeutic targeting of tumor associated macrophages.
Watkins, S. (2007) · doi:10.18297/etd/1535
Negrin, S., Olson, J. A., Leveson-Gower, D. B., Gill, S. I., Baker, J. B., Beilhack, A., & Róbert (2011)
The role of SHIP in natural killer cell licensing
Rytova, V. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0072430
Jänner, N. (2007) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15623
Role of Nitric Oxide-Signalling in Hypoxia-Induced Immune Escape in Cancer
Hamilton, T. K. (2011) · QSpace (Queen's University Library)
Mignot, G. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Regulation of Anti-viral Immunity by Dendritic Cells and Natural Killer Cells
Mbanwi, A. N. (2015) · TSpace (University of Toronto)
Gupta, N. (2013) · doi:10.21007/etd.cghs.2013.0120
Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy
Lança, T., Correia, D. V., & Silva‐Santos, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_13
Montaner, L. J. (2006) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13753.374942
Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy
Lança, T., Correia, D. V., & Silva‐Santos, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_13
Hansen, T. H. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1090944.544300
Martin, S. F. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725332833.793547203
Marin, M. L. A. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-22092022-151310
Targeting NKG2D/NKG2D ligand axis for cancer immunotherapy
Wu, J. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822620-9.00010-0
Chraa, D. (2019) · theses.fr (ABES) · doi:10.70675/8ad0de1ezeb55z4983z9084z94cc8799b353
Hazy mysteries and the major histocompatibility complex: a journey
Raulet, D. H. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag129
Self-citationViatore, M., Polidori, R., Mantovani, A., & Marchesi, F. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100167
Effects of Tumor Microenvironment on Immunity and Consequent Clinical Considerations
Baronzio, G., Freitas, I., Fiorentini, G., Crugnola, A. R., Hager, E. D., Ceppodomo, D., & Kiselevsky, M. V. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9576-4_9
Innate Immunity to Mouse Cytomegalovirus
Cekinović, Đ., Slavuljica, I., Roviš, T. L., Krmpotić, A., Polić, B., & Jonjić, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-569-5_48
Metadata
- Authors
- Diefenbach, A., Hsia, J. K., Hsiung, M. B., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2003-01-27
- Volume
- 33
- Issue
- 2
- Pages
- 381-391
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2090487140
- Cited by
- 170
- References
- 41
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 5 · 2013: 5 · 2012: 10
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, antitumor immunity, Rae1, tumor rejection, NK cell activation
- MeSH terms
- Amino Acid Sequence, Animals, Carrier Proteins, Cloning, Molecular, Cytotoxicity, Immunologic, Interferons, Killer Cells, Natural, Ligands, Macrophages, Membrane Proteins, Molecular Sequence Data, Neoplasm Transplantation, Neoplasms, Organ Specificity, Receptors, Immunologic, Recombinant Fusion Proteins, RNA, Messenger, Transfection, Transplantation, Isogeneic, Tumor Cells, Cultured, Histocompatibility Antigens Class I, Minor Histocompatibility Antigens, Lymphoma, T-Cell, Sequence Alignment, Genes, RAG-1, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Mice, Knockout, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
